Andy Batts
Long only, value, growth, momentum

AngioDynamics Turned The Corner, Solid Growth Ahead

AngioDynamics (NASDAQ:ANGO), a leading provider of medical devices for vascular access, surgery, peripheral vascular disease and oncology, has seen a dramatic turnaround in its business this year. The company anticipates that its earnings will progressively improve each quarter because of higher revenue and stronger margins of its new products. I feel that ANGO's share price will see a gradual up move from the current level. In this investment thesis I will focus on the opportunities that lie ahead of ANGO.

Business

AngioDynamics manufactures and sells a wide range of medical, surgical and diagnostic devices used by professional healthcare providers. The devices are generally used in minimally invasive, image-guided procedures. Most of the products of ANGO are intended to...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details